Established in 2006 as a Community of Reality

Welcome to the Neno's Place!

Neno's Place Established in 2006 as a Community of Reality


Neno

I can be reached by phone or text 8am-7pm cst 972-768-9772 or, once joining the board I can be reached by a (PM) Private Message.

Join the forum, it's quick and easy

Established in 2006 as a Community of Reality

Welcome to the Neno's Place!

Neno's Place Established in 2006 as a Community of Reality


Neno

I can be reached by phone or text 8am-7pm cst 972-768-9772 or, once joining the board I can be reached by a (PM) Private Message.

Established in 2006 as a Community of Reality

Would you like to react to this message? Create an account in a few clicks or log in to continue.
Established in 2006 as a Community of Reality

Many Topics Including The Oldest Dinar Community. Copyright © 2006-2020


    Bad news for Iraq and those who used the Chinese vaccine: Sinopharma admitted to "ineffective" ... a

    Rocky
    Rocky
    Rocky
    Admin Assist
    Admin Assist


    Posts : 280892
    Join date : 2012-12-21
    • Post n°1

    Bad news for Iraq and those who used the Chinese vaccine: Sinopharma admitted to "ineffective" ... a Empty Bad news for Iraq and those who used the Chinese vaccine: Sinopharma admitted to "ineffective" ... a

    Post by Rocky Sat 13 Mar 2021, 8:41 am


    [size=30]Bad news for Iraq and those who used the Chinese vaccine: Sinopharma admitted to "ineffective" ... and directed towards a third dose

    2021-03-13
    [/size]
    [You must be registered and logged in to see this link.]
    Yes Iraq: Baghdad

    The UAE health authorities revealed that the Chinese Sinopharm vaccine against the Coronavirus has not proven effective in immunizing its recipients from infection with the virus, while it began to give a third dose of the vaccine to those who took two doses of it.
    The American Wall Street Journal reported that health authorities in the UAE began administering a third dose of the Chinese vaccine to some of its residents, after doctors said that this vaccine did not produce sufficient antibodies in some cases.
    The newspaper pointed out that G42 Healthcare, which coordinated the third phase of clinical trials of the Sinopharm vaccine in the UAE and other regions in the Middle East, said that "a specific group of people will be given a third dose to monitor the immune system response" as part of a scientific study.
    But the company refused to reveal the reasons for giving this third dose and the number of people included, and referred journalists' questions to the UAE health authorities, which in turn did not respond to many requests for comment.
    For her part, the spokeswoman for the UAE government for health affairs, Dr. Farida Al Hosani, said that some people received a third booster dose of the vaccine, noting that “the number is very small” compared to the number who received the first and second doses.
    Eight people in Abu Dhabi said that they had received a third dose of the Chinese vaccine, after the public health services had called them in recent weeks, and they were all employees or contractors of government agencies in the UAE.
    They indicated that they did not participate in any scientific study, and did not undergo tests to detect antibodies, and one of them stated: “I did not get any reason or explanation when I was called. I was just asked to come to take a booster. ”
    For her part, the lead researcher in the Sinopharma vaccine trial, Dr. Nawal Al-Kaabi, said in a short message in response to an inquiry about the third doses: “It is not official and is not carried out according to a government routine.”
    Two doctors in the UAE also said that some of the Sinopharma vaccine recipients among their patients and colleagues showed little or no response in terms of the level of antibodies developed after the second dose, and it is not clear to what extent the antibody tests measure the entire immune system response to the vaccine.
    In turn, Dr. Sandeep Barge, a pulmonologist at Aster Hospital in Dubai, said that the application of the third dose of Sinopharm “did not happen according to a national policy yet,” and this dose was initially administered to people with multiple ailments, or did not develop sufficient antibodies yet The first two doses.
    Barge added that "the optimal time to obtain the third dose is six months after the previous dose, when the antibodies developed after vaccination tend to recede slightly."
    And last December, health officials in the UAE warned, in a closed meeting with government companies, that a third booster dose of the Chinese vaccine may be needed to those who do not develop an adequate antibody response after the first and second doses, as revealed by people who were Are present.
    According to the American newspaper, the detailed results of the peer review of the third phase of clinical trials of the Chinese Sinopharm vaccine have not been published, and this is in contrast to the publication of the results of full studies of vaccines, the German-American Pfizer-Biontech, the British-Swedish AstraZeneca, the American Moderna, Russia's Sputnik V, and the American Johnson & Johnson .
    [You must be registered and logged in to see this link.]
    • Back to top
      Current date/time is Sat 16 Nov 2024, 10:12 pm